Canada's Generic Drug Makers Ask Federal Leaders for their Prescription for Drug Coverage

    TORONTO, Sept. 30 /CNW/ - Canada's generic pharmaceutical industry is
asking leaders of Canada's political parties for their prescription for
improving drug coverage for Canadians, and for helping to get low-cost
Canadian-made generic drugs to developing countries.
    "Prescription drugs play an increasingly important role in Canadian
health care. They treat diseases, save lives, and enhance the quality of life
for millions of Canadians," said Jim Keon, President of the Canadian Generic
Pharmaceutical Association (CGPA). "But prescription drugs are also the
fastest growing and second largest health expenditure in Canada. Canadians
need to know how our political leaders will ensure we have access to
affordable prescription medicines when we need them."
    Today, CGPA sent its survey on prescription drug issues to the five
federal political party leaders to determine their views on critical
pharmaceutical issues for Canadians. These issues include:

    -   Making improvements to Canada's Access to Medicines Regime (CAMR) to
        ensure the program will be effective in delivering affordable
        Canadian-made generic medicines to countries facing serious health
        crises, such as the HIV/AIDS pandemic

    -   Upholding the ban on direct-to-consumer advertising of prescription

    -   Supporting the development of a national catastrophic drug coverage

    -   Achieving an appropriate balance between the financial interests of
        brand-name drug companies and costs for Canadians by ensuring the
        intellectual property regime for pharmaceuticals meets - but does not
        exceed - Canada's international trade obligations

    Copies of the survey are available on CGPA's website at

    About the Canadian Generic Pharmaceutical Association

    The Canadian Generic Pharmaceutical Association (CGPA) represents
Canada's generic drug industry - a dynamic group of companies that specialize
in the production of high quality, affordable generic drugs and fine chemicals
and in conducting the clinical trials required for government approval of
generic drugs. The industry plays an important role in controlling health-care
costs in Canada. Generic drugs are dispensed to fill 50 per cent of all
prescriptions but account for only 22 per cent of the $20-billion Canadians
spend annually on prescription medicines.

For further information:

For further information: Jeff Connell, Director of Public Affairs,
Canadian Generic Pharmaceutical Association (CGPA), Tel: (416) 223-2333, Cell:
(647) 274-3379, Email:

Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890